Table of Content

1 PD-L1 Inhibitors Market Overview
1.1 Product Overview and Scope of PD-L1 Inhibitors
1.2 PD-L1 Inhibitors Segment by Type
1.2.1 Global PD-L1 Inhibitors Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 TECENTRIQ
1.2.3 Imfinzi
1.2.4 Bavencio
1.3 PD-L1 Inhibitors Segment by Application
1.3.1 PD-L1 Inhibitors Sales Comparison by Application: (2021-2027)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global PD-L1 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PD-L1 Inhibitors Revenue 2016-2027
1.4.2 Global PD-L1 Inhibitors Sales 2016-2027
1.4.3 PD-L1 Inhibitors Market Size by Region: 2016 Versus 2021 Versus 2027

2 PD-L1 Inhibitors Market Competition by Manufacturers
2.1 Global PD-L1 Inhibitors Sales Market Share by Manufacturers (2016-2021)
2.2 Global PD-L1 Inhibitors Revenue Market Share by Manufacturers (2016-2021)
2.3 Global PD-L1 Inhibitors Average Price by Manufacturers (2016-2021)
2.4 Manufacturers PD-L1 Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 PD-L1 Inhibitors Market Competitive Situation and Trends
2.5.1 PD-L1 Inhibitors Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest PD-L1 Inhibitors Players Market Share by Revenue
2.5.3 Global PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 PD-L1 Inhibitors Retrospective Market Scenario by Region
3.1 Global PD-L1 Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global PD-L1 Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America PD-L1 Inhibitors Market Facts & Figures by Country
3.3.1 North America PD-L1 Inhibitors Sales by Country
3.3.2 North America PD-L1 Inhibitors Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe PD-L1 Inhibitors Market Facts & Figures by Country
3.4.1 Europe PD-L1 Inhibitors Sales by Country
3.4.2 Europe PD-L1 Inhibitors Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific PD-L1 Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific PD-L1 Inhibitors Sales by Region
3.5.2 Asia Pacific PD-L1 Inhibitors Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America PD-L1 Inhibitors Market Facts & Figures by Country
3.6.1 Latin America PD-L1 Inhibitors Sales by Country
3.6.2 Latin America PD-L1 Inhibitors Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa PD-L1 Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa PD-L1 Inhibitors Sales by Country
3.7.2 Middle East and Africa PD-L1 Inhibitors Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global PD-L1 Inhibitors Historic Market Analysis by Type
4.1 Global PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
4.2 Global PD-L1 Inhibitors Revenue Market Share by Type (2016-2021)
4.3 Global PD-L1 Inhibitors Price by Type (2016-2021)

5 Global PD-L1 Inhibitors Historic Market Analysis by Application
5.1 Global PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
5.2 Global PD-L1 Inhibitors Revenue Market Share by Application (2016-2021)
5.3 Global PD-L1 Inhibitors Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.2.4 AstraZeneca Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Merck KGaA
6.3.1 Merck KGaA Corporation Information
6.3.2 Merck KGaA Description and Business Overview
6.3.3 Merck KGaA PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck KGaA Product Portfolio
6.3.5 Merck KGaA Recent Developments/Updates

7 PD-L1 Inhibitors Manufacturing Cost Analysis
7.1 PD-L1 Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of PD-L1 Inhibitors
7.4 PD-L1 Inhibitors Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 PD-L1 Inhibitors Distributors List
8.3 PD-L1 Inhibitors Customers

9 PD-L1 Inhibitors Market Dynamics
9.1 PD-L1 Inhibitors Industry Trends
9.2 PD-L1 Inhibitors Growth Drivers
9.3 PD-L1 Inhibitors Market Challenges
9.4 PD-L1 Inhibitors Market Restraints

10 Global Market Forecast
10.1 PD-L1 Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of PD-L1 Inhibitors by Type (2022-2027)
10.1.2 Global Forecasted Revenue of PD-L1 Inhibitors by Type (2022-2027)
10.2 PD-L1 Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of PD-L1 Inhibitors by Application (2022-2027)
10.2.2 Global Forecasted Revenue of PD-L1 Inhibitors by Application (2022-2027)
10.3 PD-L1 Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of PD-L1 Inhibitors by Region (2022-2027)
10.3.2 Global Forecasted Revenue of PD-L1 Inhibitors by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global PD-L1 Inhibitors Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global PD-L1 Inhibitors Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global PD-L1 Inhibitors Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers PD-L1 Inhibitors Covered in This Study
Table 5. Global PD-L1 Inhibitors Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global PD-L1 Inhibitors Sales Share by Manufacturers (2016-2021)
Table 7. Global PD-L1 Inhibitors Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global PD-L1 Inhibitors Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market PD-L1 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers PD-L1 Inhibitors Manufacturing Sites and Area Served
Table 11. Manufacturers PD-L1 Inhibitors Product Type
Table 12. Global PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global PD-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-L1 Inhibitors as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global PD-L1 Inhibitors Sales by Region (2016-2021) & (K Units)
Table 16. Global PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
Table 17. Global PD-L1 Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America PD-L1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 19. North America PD-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 20. North America PD-L1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 22. Europe PD-L1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 23. Europe PD-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 24. Europe PD-L1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific PD-L1 Inhibitors Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific PD-L1 Inhibitors Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific PD-L1 Inhibitors Revenue Market Share by Region (2016-2021)
Table 30. Latin America PD-L1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 31. Latin America PD-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 32. Latin America PD-L1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa PD-L1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa PD-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa PD-L1 Inhibitors Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 38. Global PD-L1 Inhibitors Sales (K Units) by Type (2016-2021)
Table 39. Global PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 40. Global PD-L1 Inhibitors Revenue (Million US$) by Type (2016-2021)
Table 41. Global PD-L1 Inhibitors Revenue Share by Type (2016-2021)
Table 42. Global PD-L1 Inhibitors Price (US$/Unit) by Type (2016-2021)
Table 43. Global PD-L1 Inhibitors Sales (K Units) by Application (2016-2021)
Table 44. Global PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 45. Global PD-L1 Inhibitors Revenue (Million US$) by Application (2016-2021)
Table 46. Global PD-L1 Inhibitors Revenue Share by Application (2016-2021)
Table 47. Global PD-L1 Inhibitors Price (US$/Unit) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Roche PD-L1 Inhibitors Product
Table 52. Roche Recent Developments/Updates
Table 53. AstraZeneca Corporation Information
Table 54. AstraZeneca Description and Business Overview
Table 55. AstraZeneca PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. AstraZeneca PD-L1 Inhibitors Product
Table 57. AstraZeneca Recent Developments/Updates
Table 58. Merck KGaA Corporation Information
Table 59. Merck KGaA Description and Business Overview
Table 60. Merck KGaA PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Merck KGaA PD-L1 Inhibitors Product
Table 62. Merck KGaA Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. PD-L1 Inhibitors Distributors List
Table 66. PD-L1 Inhibitors Customers List
Table 67. PD-L1 Inhibitors Market Trends
Table 68. PD-L1 Inhibitors Growth Drivers
Table 69. PD-L1 Inhibitors Market Restraints
Table 70. Global PD-L1 Inhibitors Sales Forecast by Type (2022-2027) & (K Units)
Table 71. Global PD-L1 Inhibitors Sales Market Share Forecast by Type (2022-2027)
Table 72. Global PD-L1 Inhibitors Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 73. Global PD-L1 Inhibitors Revenue Market Share Forecast by Type (2022-2027)
Table 74. Global PD-L1 Inhibitors Sales Forecast by Application (2022-2027) & (K Units)
Table 75. Global PD-L1 Inhibitors Sales Market Share Forecast by Application (2022-2027)
Table 76. Global PD-L1 Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 77. Global PD-L1 Inhibitors Revenue Market Share Forecast by Application (2022-2027)
Table 78. Global PD-L1 Inhibitors Sales Forecast by Region (2022-2027) & (K Units)
Table 79. Global PD-L1 Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 80. Global PD-L1 Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 81. Global PD-L1 Inhibitors Revenue Market Share Forecast by Region (2022-2027)
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PD-L1 Inhibitors
Figure 2. Global PD-L1 Inhibitors Market Share by Type in 2020 & 2027
Figure 3. TECENTRIQ Product Picture
Figure 4. Imfinzi Product Picture
Figure 5. Bavencio Product Picture
Figure 6. Global PD-L1 Inhibitors Market Share by Application in 2020 & 2027
Figure 7. Retail Pharmacy
Figure 8. Hospital Pharmacy
Figure 9. Other
Figure 10. Global PD-L1 Inhibitors Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global PD-L1 Inhibitors Market Size 2016-2027 (US$ Million)
Figure 12. Global PD-L1 Inhibitors Sales 2016-2027 (K Units)
Figure 13. Global PD-L1 Inhibitors Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. PD-L1 Inhibitors Sales Share by Manufacturers in 2020
Figure 15. Global PD-L1 Inhibitors Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest PD-L1 Inhibitors Players: Market Share by Revenue in 2020
Figure 17. PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
Figure 19. Global PD-L1 Inhibitors Sales Market Share by Region in 2020
Figure 20. Global PD-L1 Inhibitors Revenue Market Share by Region (2016-2021)
Figure 21. Global PD-L1 Inhibitors Revenue Market Share by Region in 2020
Figure 22. U.S. PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE PD-L1 Inhibitors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of PD-L1 Inhibitors by Type (2016-2021)
Figure 47. Sales Market Share of PD-L1 Inhibitors by Application (2016-2021)
Figure 48. Sales Market Share of PD-L1 Inhibitors by Application in 2020
Figure 49. Revenue Share of PD-L1 Inhibitors by Application (2016-2021)
Figure 50. Revenue Share of PD-L1 Inhibitors by Application in 2020
Figure 51. Manufacturing Cost Structure of PD-L1 Inhibitors
Figure 52. Manufacturing Process Analysis of PD-L1 Inhibitors
Figure 53. PD-L1 Inhibitors Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed